Amplyx Pharmaceuticals Funding & Investors
San Diego, CA
Amplyx Pharmaceuticals, Inc. operates as a small molecule drug development company. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics.
amplyx.comTotal Amount Raised: $198,370,000
Amplyx Pharmaceuticals Funding Rounds
Series C
$53,000,000
Series C Investors
Sofinnova Ventures3x5 PartnersNEA - New Enterprise AssociatesLundbeckfond VenturesRiverVest Venture ManagementBioMed VenturesPfizerArix BioscienceAdage Capital ManagementPappas CapitalDebt Financing
$14,700,000
Debt Financing
$12,970,000
Series C
$67,000,000
Series C Investors
Sofinnova VenturesLundbeckfond VenturesArix BiosciencePappas CapitalNEA - New Enterprise AssociatesRiverVest Venture ManagementBioMed Ventures3x5 Special Opportunity FundGeneration VenturesSeries B
$8,700,000
Series B Investors
3x5 Special Opportunity FundSeries B
$40,500,000
Series B Investors
RiverVest Venture ManagementNEA - New Enterprise AssociatesBioMed VenturesDebt Financing
$1,500,000
Funding info provided by Diffbot.